Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia
Public ClinicalTrials.gov record NCT00080496. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Comparative Study Of The Efficacy And Safety Of Tigecycline Vs Imipenem/Cilastatin For The Treatment Of Subjects With Nosocomial Pneumonia
Study identification
- NCT ID
- NCT00080496
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Industry
- Enrollment
- 430 participants
Conditions and interventions
Conditions
Interventions
- Cilastatin Drug
- Imipenem Drug
- Tigecycline Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2003
- Primary completion
- Not listed
- Completion
- Nov 30, 2006
- Last update posted
- Aug 3, 2008
2003 – 2006
United States locations
- U.S. sites
- 29
- U.S. states
- 13
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85006 | — |
| Not listed | Phoenix | Arizona | 85013 | — |
| Not listed | Scottsdale | Arizona | 85251-6403 | — |
| Not listed | Scottsdale | Arizona | 85260-6709 | — |
| Not listed | Martinez | California | 94553 | — |
| Not listed | Modesto | California | 95350 | — |
| Not listed | Modesto | California | 95355 | — |
| Not listed | National City | California | 91950 | — |
| Not listed | Bay Pines | Florida | 33744 | — |
| Not listed | Crystal River | Florida | 34428 | — |
| Not listed | Gainesville | Florida | 32601 | — |
| Not listed | Orlando | Florida | 32806 | — |
| Not listed | Atlanta | Georgia | 30342 | — |
| Not listed | Augusta | Georgia | 30909 | — |
| Not listed | Roswell | Georgia | 30076 | — |
| Not listed | Chicago | Illinois | 60610 | — |
| Not listed | Springfield | Illinois | 62769 | — |
| Not listed | Springfield | Illinois | 62781 | — |
| Not listed | New Orleans | Louisiana | 70112 | — |
| Not listed | Shreveport | Louisiana | 71103 | — |
| Not listed | Baltimore | Maryland | 21201 | — |
| Not listed | Columbia | Missouri | 65212 | — |
| Not listed | Omaha | Nebraska | 68198-5300 | — |
| Not listed | Henderson | North Carolina | 27536 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Zanesville | Ohio | 43071 | — |
| Not listed | Philadelphia | Pennsylvania | 19102 | — |
| Not listed | Philadelphia | Pennsylvania | 19140 | — |
| Not listed | Greenville | South Carolina | 29605 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00080496, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 3, 2008 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00080496 live on ClinicalTrials.gov.